Lexicon Pharmaceuticals, Inc. (LXRX)
1.68
-0.08
(-4.55%)
USD |
NASDAQ |
Oct 09, 16:00
1.67
-0.01
(-0.60%)
Pre-Market: 08:42
Lexicon Pharmaceuticals Cash and Short Term Investments (Quarterly) : 190.61M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 190.61M |
| March 31, 2026 | 170.66M |
| December 31, 2025 | 96.23M |
| September 30, 2025 | 115.95M |
| June 30, 2025 | 139.01M |
| March 31, 2025 | 194.84M |
| December 31, 2024 | 237.96M |
| September 30, 2024 | 258.37M |
| June 30, 2024 | 309.96M |
| March 31, 2024 | 355.60M |
| December 31, 2023 | 170.03M |
| September 30, 2023 | 218.43M |
| June 30, 2023 | 256.74M |
| March 31, 2023 | 105.94M |
| December 31, 2022 | 138.36M |
| September 30, 2022 | 136.20M |
| June 30, 2022 | 61.97M |
| March 31, 2022 | 86.50M |
| December 31, 2021 | 86.74M |
| September 30, 2021 | 120.92M |
| June 30, 2021 | 118.50M |
| March 31, 2021 | 141.36M |
| December 31, 2020 | 152.28M |
| September 30, 2020 | 111.45M |
| June 30, 2020 | 201.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 249.14M |
| December 31, 2019 | 271.66M |
| September 30, 2019 | 296.30M |
| June 30, 2019 | 105.98M |
| March 31, 2019 | 133.14M |
| December 31, 2018 | 160.05M |
| September 30, 2018 | 187.30M |
| June 30, 2018 | 209.69M |
| March 31, 2018 | 262.27M |
| December 31, 2017 | 310.79M |
| September 30, 2017 | 196.82M |
| June 30, 2017 | 231.19M |
| March 31, 2017 | 259.74M |
| December 31, 2016 | 346.50M |
| September 30, 2016 | 395.56M |
| June 30, 2016 | 429.36M |
| March 31, 2016 | 477.15M |
| December 31, 2015 | 521.35M |
| September 30, 2015 | 256.42M |
| June 30, 2015 | 282.48M |
| March 31, 2015 | 315.10M |
| December 31, 2014 | 339.34M |
| September 30, 2014 | 57.87M |
| June 30, 2014 | 79.04M |
| March 31, 2014 | 98.37M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 11.07B |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |
| Veru, Inc. | 25.79M |
| Johnson & Johnson | 20.76B |